Navigation Links
Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer
Date:6/24/2008

mpany focused on developing fully human antibody therapeutics for unmet medical needs. Using cutting-edge antibody technology, Genmab's world class discovery, development and manufacturing teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors. Genmab is not under an obligation to up-date statements regarding the future following the publication of this release; nor to confirm such statements in relation to actual results, unless this is required by law.

Genmab(R); the Y-shaped Genmab l
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
2. Genmab Announces Updates on Phase III Cancer Studies
3. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
4. Bionomics Achieves US$1 Million Milestone Payment from Genmab
5. DAHANCA Initiates Head and Neck Cancer Study With Genmabs HuMax-EGFr
6. iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix
7. Peptimmune Initiates Phase Ib Study of PI-2301 in Multiple Sclerosis Patients and Presentation at BIO 2008
8. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
9. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
10. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
11. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013   Accuray Incorporated ... publication of study results involving hundreds of prostate ... System, the most widely used form of prostate ... 304 patients for a median of 5 years, ... that 97 percent of patients with low-risk and ...
(Date:5/21/2013)... ORLANDO, Fla. , May 21, 2013 /PRNewswire/ ... and safety results from the global Phase 3 ... protease inhibitor simeprevir (TMC435) led to sustained virologic ... (SVR12) in 79 percent of treatment-experienced genotype 1 ... disease, including all stages of liver fibrosis, when ...
(Date:5/21/2013)... , May 21, 2013 Abaxis, Inc. ... analysis systems, announced today that Martin Mulroy ... the Stifel Annual Dental & Veterinary Conference on Wednesday, ... will be held at Le Parker Meridien Hotel in ... About Abaxis Abaxis develops, manufactures, markets and ...
Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2
... Sept. 9, 2011 Valeant Pharmaceuticals International, Inc. (" Valeant ... of Afexa Life Sciences Inc. (" Afexa ") its offer ... friendly offer (the " Offer ") for all of the ... at a price of C$0.71 in cash per Common Share. ...
... YORK, Sept. 8, 2011 NeoStem, Inc. (NYSE ... "Company"), an international biopharmaceutical company with a focus ... presenting at three upcoming September conferences: the Rodman ... Commercialization Summit, and the JMP Securities Healthcare Conference. ...
Cached Medicine Technology:Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 2Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 3Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa 4NeoStem Announces Participation in Multiple September Conferences 2NeoStem Announces Participation in Multiple September Conferences 3
(Date:5/21/2013)... A new study appearing in the current ... cells harvested from fat (adipose) are more potent than ... the body’s immune system. , The finding could ... adipose tissue-derived stem cells (AT-SCs) are far more plentiful ... and can be collected from waste material from liposuction ...
(Date:5/21/2013)... Idaho (PRWEB) May 21, 2013 The ... 26 million people in the United States of America ... patients are at a great risk of developing peripheral ... lead normal lives. The ADA further goes on saying ... 20 years and around 2 million new cases are ...
(Date:5/21/2013)... Australia (PRWEB) May 22, 2013 About ... made the Fertility Clinics industry one of ... industry assists patients who are unable to conceive naturally ... and popular of which is in-vitro fertilisation (IVF) cycles. ... IVF cycles in Australia has increased by 4.4% per ...
(Date:5/21/2013)... (HealthDay News) -- Aggressive treatment for prostate cancer ... with underlying medical conditions, a new study finds. ... radiation and radioactive seed implants, can cause serious ... and bowel problems, explained researchers from the University ... found that older patients with slower growing forms ...
(Date:5/21/2013)... University in St. Louis announced today that it ... funded by the Bill & Melinda Gates Foundation. ... environmental & chemical engineering, will pursue an innovative ... Killing of Parasite Eggs by Probiotic Organisms." , ... explore ideas that can break the mold in ...
Breaking Medicine News(10 mins):Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary 2Health News:Gates Fellowship addresses parasite infection in developing world 2
... study has dismissed any association between consumption of dairy products ... total calcium intake//, and consequent changes in body weight. Diet ... calcium. ,More than 19,000 men between the age ... period. All of the study participants consumed a normal diet ...
... immense health benefits. Now, teens, who want that dream weight, ... keep obesity at bay, according to a new study. Researchers ... which combined yoga with breathing exercises certainly helped knock off ... and boys participated in a study. They were divided into ...
... of live chicken and eggs appear to have scaled ... initial fear of a bird flu outbreak abated.// ... Coordination Committee (NECC), “There has been some improvement in ... well as within the state in the last four ...
... report by the Canadian Institute for Health Information (CIHI) ... of money there has been no shortening of waiting ... said that the volume of diagnostic tests and high-priority ... care seems to have increased just as much. Statistics ...
... a new study claims that calcium intake was not associated ... study was published in the American Journal of Clinical Nutrition. ... who were enrolled in the Health Professionals Follow-up Study were ... and relation between total calcium intake from diet and supplements ...
... disease in eastern Sarawak state of Malaysia is causing concern ... shut down all schools in the area to prevent the ... virus, which causes the disease, has so far affected more ... it. "In peninsular Malaysia, the health ministry will take a ...
Cached Medicine News:
2.5x8mm Spatula Combined with 8mm Blade; in stainless steel....
0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
Bend with "H" Shaped Tip, Right; Stainless Steel....
... Perfusion Catheter is indicated for ... portion of a coronary artery ... the purpose of improving myocardial ... are also designed to provide ...
Medicine Products: